Skip to Main Content
  • Become an Access Reviewer
  • Clinical Phenotypes
  • OMMBID Advisory banner
  • Ommbid banner
  • Ommbid latest banner



  1. For many human diseases, the fundamental defect resides in a simple alteration in the genome—the master blueprint of DNA that orchestrates the basic operation of a cell and an organism. Genetic studies often provide the ability to define at a molecular level the nature of such DNA alterations (i.e., mutations). Knowledge of the normal and abnormal forms of genes is invaluable for understanding the basis of many human genetic diseases.

  2. The haploid human genome consists of ≈3 billion base pairs (bp) of DNA that are distributed among 24 distinct chromosomes (22 autosomes and 2 sex chromosomes). Within this vast array of nucleotides are encoded an estimated 50,000 to 100,000 genes and the necessary elements that control the regulation of their expression.

  3. Analyzing a genome involves the construction of various types of maps that reflect different features of the DNA, with the major classes being cytogenetic maps, genetic maps, and physical maps. The highest-resolution physical map is the DNA sequence map, which reflects the precise order of nucleotides along a chromosome. Important technological advances have produced a number of powerful methods that greatly facilitate the ability to analyze genomes.

  4. The Human Genome Project (HGP) is a large, coordinated effort to elucidate the genetic architecture of the human genome and, in parallel, that of several model organisms. The initial phase of this endeavor has mostly involved constructing relatively low-resolution genomic maps and refining the approaches for large-scale DNA sequencing. The next phase of the HGP will focus more on establishing the complete nucleotide sequence of the human and other genomes as well as beginning to decipher the encoded information systematically.

  5. The products of the HGP are providing a detailed working knowledge about the organization of human DNA and that of several model organisms as well as an infrastructure (in the form of biologic, informational, and technological tools) that is already ushering in a spectacular new era of biomedical inquiry. From a clinical viewpoint, this infrastructure is facilitating the identification and characterization of genes that directly and indirectly lead to human disease, which in turn should ultimately improve the ability to diagnose and treat affected individuals.

Want remote access to your institution's subscription?

Sign in to your MyAccess profile while you are actively authenticated on this site via your institution (you will be able to verify this by looking at the top right corner of the screen - if you see your institution's name, you are authenticated). Once logged in to your MyAccess profile, you will be able to access your institution's subscription for 90 days from any location. You must be logged in while authenticated at least once every 90 days to maintain this remote access.


About MyAccess

If your institution subscribes to this resource, and you don't have a MyAccess profile, please contact your library's reference desk for information on how to gain access to this resource from off-campus.

Subscription Options

OMMBID Full Site: One-Year Subscription

Connect to the full suite of OMMBID content including new and revised chapters that reflect the latest research, image galleries, clinical phenotypes, and more.

$295 USD
Buy Now

Pay Per View: Timed Access to all of OMMBID

24 Hour Subscription $34.95

Buy Now

48 Hour Subscription $54.95

Buy Now

Pop-up div Successfully Displayed

This div only appears when the trigger link is hovered over. Otherwise it is hidden from view.